NCT02365558View on ClinicalTrials.gov

A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

Evacetrapib

Administered orally

DRUG

Omeprazole

Administered orally

Trial Locations (1)

53704

Covance Madison, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02365558 - A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants | Biotech Hunter | Biotech Hunter